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[571 ABSTRACT 
Microspheres of acrolein homopolymers and copoly- 
mer with hydrophillic comonomers such as methacrylic 
acid and/or hydroxyethylmethacrylate are prepared by 
cobalt gamma irradiation of dilute aqueous solutions of 
the monomers in presence of suspending agents, espe- 
cially alkyl sulfates such as sodium dodecyl sulfate. 
Amine or hydroxyl modification is achieved by forming 
adducts with diamines or alkanol amines. Carboxyl 
modification is effected by oxidation with peroxides. 
Pharmaceuticals or other aldehyde reactive materials 
can be coupled to the microspheres. The microspheres 
directly form antibody adducts without agglomeration. 
11 Claims, 4 Drawing Figures 
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POLY ACROLEIN MICROSPHERES 
ORIGIN OF THE INVENTION 
The invention described herein was made in the per- 
formance of work under a NASA contract and is sub- 
ject to the provisions of Section 305 of the National 
Aeronautics and Space Act of 1958, Public Law 83-568 
(72 Stat. 435; 42 USC 2457). 
This is a division of application Ser. No. 248,899 filed 
Mar. 30, 1981, now U.S. Pat. No. 4,413,070. 
TECHNICAL FIELD 
The present invention relates to the synthesis of 
polyacrolein microspheres, functional derivatives 
thereof, fluorescent and magnetic variations thereof, 
protein conjugates thereof and to the use of the conju- 
gates in biological and chemical research and testing. 
BACKGROUND OF THE PRIOR ART 
The isolation and characterization of cell membranes 
and their components is essential for an understanding 
of the role in which surface membranes play in regulat- 
ing a wide variety of biological and immunological 
activities. The present techniques used for this purpose 
are not quite satisfactory. 
Knowledge of the nature, number and distribution of 
specific receptors on cell surfaces is of central impor- 
tance for an understanding of the molecular basis under- 
lying such biological phenomena as cell-cell recognition 
in development, cell communication and regulation by 
hormones and chemical transmitters, and differences in 
normal and tumor cell surfaces. In previous studies, the 
localization of antigens and carbohydrate residues on 
the surface of cells, notably red blood cells and lympho- 
cytes, has been determined by bonding antibodies or 
lectins to such molecules as ferritin, hemocyanin or 
peroxidase which have served as markers for transmis- 
sion electron microscopy. With advances in high reso- 
lution scanning electron microscopy (SEM), however, 
the topographical distribution of molecular receptors 
on the surfaces of cell and tissue specimens can be 
readily determined by similar histochemical techniques 
using newly%developed markers resolvable by SEM. 
Recently, commercially available polystyrene latex 
mrticles have been utilized as immunologic markers for 
2 
chemicals containing amino groups to the polymeric 
bead. Methacrylic acid residues which impart a nega- 
tive charge onto the particles are likely to prevent non- 
specific binding to cell surfaces and to provide carboxyl 
5 groups to which a variety of biochemical molecules can 
be covalently bonded using the carbodiimide method. 
The derivatization procedure is unnecessarily com- 
plex and requires an additional step to prepare the bead 
surface for covalently binding to proteins such as anti- '' bodies, lectins and the like or other molecules such as 
DNA, hormones and the like. Therefore, the method of 
derivatization of acrylic microbeads is tedious and 
availability is limited. Monomeric glutaraldehyde has 
been used as a biochemical reagent to covalently bond 
l 5  proteins such as immunoglobulins to ferritin polymeric 
microspheres and other small particles which were then 
utilized to map receptors on cell membranes. However, 
the reaction mechanism of proteins with glutaraldehyde 
2o is difficult to ascertain since its structure is still not clear 
and it has been reported to be in equilibrium with cyclic 
and hydrated forms. The reaction is difficult to carry 
out and frequently gives unsatisfactory results. 
Direct protein bonding polyglutaraldehyde or co- 
25 polymers therefore disclosed in copending application 
Ser. Nos. 21,988, now issued as U.S. Pat. Nos. 4,267,235, 
and 21,989, now issued as U.S. Pat. No. 4,267,234, both 
filed Mar. 19, 1979 prepared by solution polymerization 
in aqueous basic medium. In contrast to monomeric 
30 glutaraldehyde, the polymers contain conjugated alde- 
hyde groups. This imparts stability to the Schiff's bases 
formed after reaction with proteins and, further, since 
the hydrophilic polyglutaraldehyde has relatively long 
chains extending from the surface into the surrounding 
35 aqueous medium, the heterogenous reaction with pro- 
tein is facilitated. 
Polyglutaraldehyde (PGL) microspheres can be di- 
rectly prepared by suspension polymerization with stir- 
ring in presence of surfactant or by precipitation from 
40 solution containing surfactant. Magnetic, high density 
or electron dense microspheres can be prepared by 
coating metal particles or by suspension polymerization 
of glutaraldehyde in presence of a suspension of finely 
divided metal or metal oxide. It has been determined 
45 that the PGL microspheres exhibit some degree of non- 
specific binding to cells. Moreover, though' some cross- 
linking occurs during the homopolymerization of glu- . ise in the SEM technique. The surface 0'. such polysty- 
macromolecules such as antibodies are absorbed on the 
surface under carefully controlled conditions. How- 50 
ever, such particles stick non-specifically to many sur- 
faces and molecules and this seriously limits their broad 
application. 
The preparation of small, stable spherical Poly-Hema 
rene particles is hydrophobic and hence certain types Of taraldehyde, the polymer can be dissolved in highly 
polar solvents. 
A process for polymerizing unsaturated aldehydes 
such as acrolein is disclosed in U.S. Pat. No. 3,105,801. 
The process comprises adding a small amount of acid or 
an acid-acting material to an aqueous solution contain- 
the acidic medium to high energy ionizing radiation to 
particles which are biocompatible, i.e., do not interact 55 ing Or Other unsaturated and 
non-specifically with cells or other biological 
nents and which contain functional groups to which 
specific proteins and other biochemical molecules can 
high molecular weight polymer in the of 
light powders having non-uniform shapes and shes. The 
be covalently bonded is disclosed in U.S. pat. N ~ .  polymers were not utilized as such but are dissolved in 
3,957,741. 60 aqueous alkaline sulfur dioxide solution to form water 
Smaller, more evenly shaped acrylic microspheres soluble derivatives which are used as coatings or sizings 
are disclosed in U.S. Pat. No. 4,138,383. Microspheres for Paper, Cloth, fibers and the like. Bell et a1 also dis- 
having a density differing from that of cell membranes cusses the copolymerization of acrolein with a wide 
are disclosed in U.S. Pat. No. 4,035,316 and fluorescent- variety of ethylenically unsaturated monomers such as 
acrylic copolymer microspheres are disclosed in Serial 65 ethylene diamine, pyridine or acrylic acids or esters, 
No. 718,104 filed Aug. 27, 1976, now abandoned. vinyl halides, etc. in amounts from 0.1 to 60%, prefera- 
The hydroxyl groups can be activated by cyanogen bly from 1% to 25% by weight of the monomer mix- 
bromide for covalent bonding of proteins and other ture. 
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The monomer mixture can contain other agents such 
as stabilizing, suspending and emulsifying agents. Radi- 
ation accelerators such as halides or metal salts may be 
added to the reaction mixture. 
a high degree of available aldehyde function, there was 
no recognition of the use of such material as a biological 
lated to contain metals which can be utilized to form 
election dense magnetic non-aggregating particles or 
magnetic coatings or films. The microspheres of the 
invention provide a reliable, simple method to label 
The microspheres of the invention can also be utilized 
as a substrate to bind pharmaceutica]s containing func- 
Though the poiyacroleins prepared by Bell et a1 have 5 cells for research or analysis. 
reagent. Furthermore, the presence of extraneous ingre- 
dients interferes with the purity Of the polymer and it tional groups reactive with aldehyde, the hydrophillic hydroxyl, carboxyl or amine substituent or the func- would not be suitable as a biochemical protein bonding I O  tional group 
agent. Furthermore, specific modification of the mate- 
rial by coDolymerization with certain comonomers de-’ 
of the adduct. The microsphere-phar- 
maceutical adduct is less likely to migrate and should 
signed to Impart further properties such as non-specific 
binding and modification to add other functional groups 
for introduction of dyes, proteins or other materials 
would improve the flexibility of use of the material. 
DESCRIPTION OF THE INVENTION 
Novel acrolein interpolymer microspheres and func- 
tional, modified reaction products and protein adducts 
thereof, are produced in accordance with the invention. 
The size and properties of the microspheres can be 
controlled by selection of polymerization conditions 
and especially by selection of comonomers. The micro- 
spheres of the invention exhibit exceptional stability and 
can be derivatized by reaction with amines or with 
proteins without aggregation. 
The non-aggregating microspheres are produced in 
accordance with this invention by the high-energy initi- 
ated interpolymerization of an unsaturated alifehyde 
such as acrolein and at least 20% by weight of at least 
one addition copolymerizable comonomer having a 
hydrophilic functional substituent selected from hy- 
droxyl, amino or carboxyl. 
Another manner of introducing functionality other 
than aldehyde onto the microspheres is by adduct reac- 
tion of the microspheres with compounds of the for- 
mula: 
where R1 is hydrogen or a hydrocarbon group which 
may be aliphatic or aromatic preferably aryl such as 
phenyl or alkyl of 1 to 10 carbon atoms, R is a divalent 
hydrocarbon group such as alkylene of 1 to 20 carbon 
atoms and Z is a functional group such as amine or 
hydroxyl or RZ can be hydroxyl. Representative com- 
pounds are hydroxylamine or ethylene diamine. The 
microspheres can be modified to introduce carboxyl 
groups by oxidation with an agent such as hydrogen 
peroxide. 
The microspheres of the invention exhibit little or no 
aggregation during or after derivatization reaction to 
introduce large amounts of antibodies or other proteins, 
fluorochromes, etc. The microspheres are insoluble, 
have functional groups directly reactive with protein, 
are easily dispersed and bind specifically to receptor 
sites and can be readily prepared in sizes from 100 Ang- 
stroms to 2,000 Angstroms, or up to 10 microns or 
larger if desired. 
The derivatization procedure is simplified. The hy- 
droxyl modified microspheres can be used to chelate 
metals as a purification media or as a support for a cata- 
lyst. The microspheres can be formed into a strong 
transparent film by drying on a surface or can be formu- 
reduce side effects. Furthermore, antibodies can be 
attached to the microsphere so that it migrates to spe- 
cific cells having corresponding antigen receptor sites. 
l 5  Magnetic microspheres can be accumulated at a specific 
location in a subject by application of a magnetic field 
to that location. 
These and many other features and attendant advan- 
20 tages of the invention will become apparent as the in- 
vention becomes better understood by reference to the 
following detailed description when considered in con- 
junction with the accompanying drawings. 
BRIEF DESCRIPTION OF THE DRAWINGS 
FIG. 1 is a series of graphs showing the effect of 
addition of comonomers on the size of acrolein copoly- 
mer microspheres. 
FIG. 2 is a series of schematic reactions of polya- 
30 crolein microspheres and various modifying and ad- 
ducting reagents; 
FIG. 3 is a pair of curves illustrating the aldehyde and 
carboxyl content of oxidized Acrolein-Methacrylic 
Acid copolymer microspheres; and 
FIG. 4 is a pair of curves demonstrating the kinetics 
of reaction of polyacrolein microspheres with an anti- 
body. 
DETAILED DESCRIPTION OF THE 
25 
35 
40 INVENTION 
Initiation of copolymerization by high energy radia- 
tion in absence of chemical initiators or acid materials 
provides a purer and more evenly sized and shaped 
microsphere. The microspheres are produced by addi- 
45 tion polymerization of a liquid polymerization system 
optionally including a dispersion of the metal particles 
in a monomer mixture containing a covalently bondable 
unsaturated monomer. More uniformly sized and 
shaped beads are formed in very dilute aqueous mono- 
50 mer mixtures of no more than 5% by weight, preferably 
1 to 4% by weight of dissolved monomers. Surfactants 
may be present to aid in the dispersion of the metal 
particles and in suspending the microspheres. 
The polymerization proceeds with or without stirring 
with application of high energy radiation capable of 
generating free radicals in the aqueous system. The 
radiation source is suitably a cobalt 60 gamma source or 
cesium source and doses of 0.05 to 2.0 megarads are 
60 sufficient for polymerization. It is believed that polymer 
chains grow from the surface of metallic particles. The 
reaction is preferably conducted under oxygen exclud- 
ing condition, generally by applying vacuum to the 
reaction vessel or by displacing oxygen gas from the 
65 system with an inert gas such as nitrogen. After poly- 
merization has proceeded to completion, the reaction 
mixture is made neutral by adding acid or base, passed 
through mixed ion exchange resins to remove emulsifi- 
55 
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ers or any free metal particles. Further purification is 
achieved by centrifugation on a sucrose gradient. 
The addition of 0.05 to 5%, by weight, of a stabilizing 
agent to the aqueous polymerization system before pol- 
ymerization is found to further reduce agglomeration. 
The stabilizing agent is suitably an aqueous soluble 
polymer such as a polyalkylene oxide polyether or non- 
ionic surfactants such as Tween which are polyoxyeth- 
ylene derivatives of fatty acid partial esters of sorbitol, 
Triton X, or dextrans. The polyethers generally have a 
molecular weight from 10,000 to 10,000,000, preferably 
400,000 to 6,000,000 and are polymers of ethylene ox- 
ide, propylene oxide or their mixtures. Polyethylene 
oxides (PEO) and Triton X are preferred. 
The smaller microspheres (50 to 200 Angstroms in 
diameter) are formed in solutions containing small 
amounts, typically from 10 to 150 millimoles, of an 
alkali metal. Cs to C2o alkyl sulfate surfactant such as 
sodium lauryl sulfate (SLS) or sodium dodecyl sulfate 
(SDS). 
The ethylenically unsaturated aldehydes should com- 
prise at least 10% by weight of the monomer mixture 
preferably from 20% to 90% by weight thereof. The 
aldehydes preferably have the ethylenic group in alpha- 
beta position relative to the aldehyde group and can be 
selected from those aldehydes containing up to 20 car- 
bon atoms such as acrolein, methacrolein, alpha-ethyl 
acrolein, alpha-butylacrolein, alpha-chloroacrolein, 
beta-phenylacrolein, alpha-cyclohexyl acrolein and al- 
pha-decylacrolein. Preferred aldehydes contain 4 to 10 
carbon atoms and especially acrolein and C1 to Cg aryl 
alkyl and cycloalkyl substituted derivatives thereof. 
The mono-unsaturated covalent-bonding monomers 
are freely water soluble and should comprise from 10 to 
50% of the monomer mixture. These monomers are 
suitably selected from amino, carboxyl or hydroxyl 
substituted acrylic monomers. Exemplary monomers 
are acrylamide (AM), methacrylamide (MAM), acrylic 
acid, methacrylic acid (MA), dimethylaminomethacry- 
late or hydroxyl-lower alkyl or amino-lower-alkyl- 
acrylates such as those of the formula: 
CH2 0 
II II 
RI-c-c-RZ-Z 
where R1 is hydrogen or lower alkyl of 1-8 carbon 
atoms, R2 is alkylene of 1-12 carbon atoms, and Z 
is-OH or R3-N-R4 where R3 or R4 are individually 
selected from H, lower alkyl or lower alkoxy of 1-8 
carbon atoms. 2-hydroxyethyl methacrylate (HEMA), 
3-hydroxypropyl methacrylate and 2-aminoethyl meth- 
acrylate are readily available commercially. Porosity 
and hydrophilicity increase with increasing concentra- 
tion of monomer. 
Inclusion of polyunsaturated compounds provides 
cross-linked beads. The polyunsaturated compounds 
are generally present in the monomer mixture in an 
amount from 0.1-20% by weight, generally 6-12% by 
weight and are suitably a compatible diene or triene 
polyvinyl compound capable of addition polymeriza- 
tion with the covalent bonding monomer such as ethyl- 
ene glycol dimethacrylate, trimethylol-propane-trime- 
thacrylate, N,N'-methylene-bis-acrylamide (BAM), 
hexahydro-1,3,5-triacryloyl-s-triaine or divinyl ben- 
zene. 
For small particle size and additional reduction in 
non-specific binding and agglomeration the monomer 
mixture preferably contains a monomer capable of im- 
parting negative charge such as methacrylic acid (MA). 
6 
The mixture may contain 040% suitably 10 to 30% of 
sparingly water soluble monomers having hydrophobic 
characteristics since this is found to result in freely-sus- 
pended, individual, small beads. The cross-linking agent 
5 is sometimes sparingly water soluble. Hydrophobic 
characteristics can also be provided with monomers 
such as lower alkyl acrylates suitably methyl methacry- 
late or ethyl methacrylate or a vinyl pyridine. Vinyl 
pyridines suitable for use in the invention are 2-vinyl 
10 pyridine, 4-vinyl pyridine and 2-methyl-5-vinyl pyri- 
dine. 
Small microspheres (of the order of 100 to 500 Ang- 
stroms) containing electron-dense metals provide 
higher spatial resolution of cell surface features. Im- 
l 5  munomicrospheres containing electron-dense metals 
provide more stable labels than gold particles with 
physically absorbed antibodies that are presently used 
for cell labeling. The metal containing microspheres can 
be synthesized by, in situ, polymerization of the micro- 
2o spheres in presence of a suspension of finely-divided 
metal particles or compounds of the metal, preferably a 
colloidal dispersion of the metal. The metal is incorpo- 
rated into the microsphere in an effective amount of 
from 0.5% to 40% by weight, generally from 5% to 
The metal or metal compound particles are prefera- 
bly fine, evenly sized materials having a uniform diame- 
ter smaller than the :esultant microspher: diamety, 
3o typically below 1000 A, generally from 25 A to 500 A. 
The metals are preferably the electron-dense heavy 
metals having a high atomic number above 50, prefera- 
bly above 75 such as Pb, Ni, Co, Pt, Au, Fe. The metal 
may be magnetically attractable such as Fe, Ni, Co or 
35 alloys thereof or an inorganic magnetic compound such 
as a metal oxide. The magnetic material is preferably a 
magnetic iron oxide of the formula Fe304. Some hard, 
ceramic type ferrites, such as lithium ferrites can also be 
used. The metal or compound can be made into a 
40 readily dispersible form by suspension in water contain- 
ing a surfactant such as polyethylene imine. 
Post polymerization reaction with specific fluoro- 
crome reagents that are not in themselves fluorescent, 
results in a fluorescent microsphere by forming fluores- 
45 cent chromophores attached to the polymer. Anthrone 
reacts with acrolein units to form a benzanthrone 
fluorogen and m-aminophenol reacts with the acrolein 
structure to form the fluorogen, 7-hydroxyquinoline. 
Aminofluorescein also reacts with aldehyde groups to 
The microspheres can also be rendered fluorescent 
during polymerization in presence of fluorochrome 
compounds containing ajdehyde or hydroxyl reactive 
groups such as aminofluorescein, 9-amino acridine, 
55 propidium bromide or fluorescein isothiocyanate 
(FITC). Highly fluorescent microspheres can also be 
prepared by suspension polymerization in presence of 
fluorochromes containing unsaturated groups capable 
of reaction with acrolein. Examples of practice follow: 
25 25% by weight. 
50 form fluorescent microspheres. 
60 Reagents 
Methacrylic acid (MA), 2-hydroxyethyl methacry- 
late (HEMA), acrolein, ethylene diamine were fraction- 
ally distilled. Polyethylene oxide (PEO, M, 100000) 
65 N,N-methylene-bis-acrylamide (BAM), hydroxylamine 
hydrochloride, 1,6-hexane diamine, l.Lysine, l-ethyl-3- 
(3-dimethyl amino propyl) carbodiimide were used as 
received. 
7 
Synthesis 
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8 
copolymer (35 mol percent HEMA) microsphere sus- 
pension to dryness results in a strong, flexible film. 
EXAMPLE 3 
Seven of the copolymers were reacted with hydroxy- 
lamine chloride to form hydroxyl functional micro- 
spheres. The aldehyde content was analyzed by this 
procedure as shown in Table I. 
Acrolein or monomer mixtures consisting of HEMA 
and acrolein or HEMA, BAM, MA and acrolein 
formed homogeneous solutions in distilled water con- 5 
taining 0.4% PEO or 64 mM of SDS. After dearation 
with nitrogen the mixtures were irradiated in CO 
gamma source at room temperature (dose rate 0.12 
TABLE 1 
HEMA ACROLEIN MICROSPHERES 
Determination of aldehyde functional groups by reaction with hydroxylamine hydrochloride 
% (v/v) Acrolein Mole % Microspheres/mgb x % Nitrogen per mg x per microsphere x 
30 44 61.1 0.84 3.06 1.4 17.0 
40 55 50.0 3 .1  4.02 1.8 5.8 
50 65 47.9 3.7 4.84 2.2 5.9 
60 74 37.8 4.6 5.59 2.5 5.4 
70 82 36.3 6.5 6.57 3.0 7.6 
RO 88 21.6 5.2 8.58 4.0 7.8 
Number of Aldehyde Groups 
of Total Monomer Acroleinu % Yield 10-10 FoundC 10-7 
..
100 loo 17.6 6.4 13.06 6.4 10.0 
“Mole % of acrolein in monomer mixture. 
kalculated usinr mherical microsnheres of diameter shown on FIG. 1 and a density of 1.2 g/ml. 
L .  
Theoretical nitrogen for homopolymer is 19 72% 
Mrhour) for 4 hours. The reaction product was puri- 
fied by three centrifugations and kept in distilled water. 
Methods 
The aldehyde content was determined from the per- 
cent nitrogen of the oxime prepared by the reaction of 30 
an aqueous suspension with hydroxylamine hydrochlo- 
ride [P. J. Bochert Kunstoffe 51 (3) 137 (1961)l. IR 
spectra were obtained with a Fourrier transform IR 
(fts-l5C, Houston Instruments) spectrophotometer. 
EXAMPLE 1 
Pure acrolein (5% v/v) in water containing PEO 
produced colloidal particles (approximately 1 ,OOO Ang- 
stroms in diameter) after cobalt gamma irradiation. 
Repeat of the procedure substituting 64 mM SDS for 40 
PEO resulted in 170 Angstrom microspheres in higher 
yield. 
EXAMPLE 2 
different HEMA contents were prepared by cobalt 
gamma irradiation of a 5% (v/v) monomer solution in 
water containing 0.4% PEO. The diameter of the re- 
sulting microspheres decreased with increasing acrolein 
content as shown in FIG. 1. Over the middle of the 50 
concentration range studied, monomer ratios had little 
effect on size; permitting the preparation of micro- 
spheres of similar size but different degrees of hydro- 
phobicity. 
35 
Acrolein-HEMA copolymer microspheres of eight 45 
The acrolein homopolymer (100% acrolein) was 
found to contain approximately 65% of the expected 
aldehyde groups. The presence of aldehyde groups was 
further confirmed by IR spectra analysis which showed 
a high intensity peak at 1725 cm-1. Adducts and reac- 
tion products are depicted in FIG. 2. 
EXAMPLE 4 
The hydroxylamine modified copolymer micro- 
pheres containing 35% mol HEMA were impregnated 
with an aqueous solution of copper salt. The copper 
ions reacted with the microspheres to form metal che- 
late adducts. 
EXAMPLE 5 
Cross-linked microspheres containing acid functions 
were produced by adding MA and BAM to the 
HEMA-Acrolein monomer mixture. The porosity of 
the microsphere was significantly increased as evi- 
denced by swelling (uptake of liquid). However, the 
size of the cross-linked microspheres closely approxi- 
mated that of the HEMA-ACROLEIN microspheres of 
Example 2 as shown in FIG. 1. By addition of increas- 
ing amounts of BAM to acrolein the hydrophilicity of 
acrolein spheres could be progressively increased. 
EXAMPLE 6 
One of the BAM-MA-HEMA-Acrolein copolymers 
was reacted with various diamine to form amine-modi- 
fied adducts. The results are shown in Table 2. 
TABLE 2 
REACTION OF POLY ACROLEIN MICROSPHERES WITH DIAMINESu 
Reactant pH % Nitrogen per mg per microsphere pH % Nitrogen per mg per microsphere 
1,2 diaminoethane 3.0 1.43 3.2 x I O l 7  2.4 x IO7 11.3 4.88 1.2 x 10l8 9.2 X IO7 
1.2 diaminohexane 3.0 0.78 8.6 x 10l6 6.6 x IO6 11.7 3.11 8.2 x lOI7 6.3 X IO7 
L-Lysine 3.2 0.40 8.8 X 6.8 X lo6 9.0 2.41 5.9 X IOl7 4.5 X lo7 
“Reaction mixture for microsphere synthesis; 35.9 mole % acrolein, 56.9 mole % HEMA, 5.9 mole % methacrylic acid 1.3 mole % bisacrylamide. 
Number of Free Amino Groups No. of Free Amino Groups 
65 It was found that at high pH the number of free amino 
When the acrolein homopolymer microsphere sus- groups was comparable to the number of aldehyde 
pension was evaporated to dryness, a brittle film was groups found by hydroxylamine analysis. This reaction 
formed. However, evaporation of the HEMA- allows the efficient conversion of aldehyde functions to 
9 
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amine functions, removed from the surface of the 
spheres by a two to six carbon spacer arm. 
The monomer mixture utilized in the experiment in 
Table 2 was modified by maintaining the ratio of 
HEMA, MA and BAM constant while adding increas- 
ing amounts of acrolein. As shown in Table 3 which 
follows, the aldehyde content increased with increasing 
acrolein content proving that acrolein was being incor- 
porated into the copolymer. 
TABLE 3 
10 
No. ALDEHYDE 
GROUPWmg x 
MOLE % ACROLEIN % N 10-18 
35.9 3.26 1.35 15 
58.5 4.32 1.93 
75.8 6.57 2.90 
95.3 12.16 5.83 
20 
EXAMPLE 7 
The copolymer of Example 6 was reacted with an 
adduct of fluorescein isothiocyanate (FITC) and 1,6- 
diamino-n-hexane which resulted in microspheres of 
high fluorescent intensity. 25 
EXAMPLE 8 
An allyl amine adduct of FITC was prepared. Addi- 
tion of 0.1 % by weight of the adduct to the polymeriza- 
tion system of Example 6 resulted in an addition inter- 
polymerized fluorescent copolymer microsphere. 
EXAMPLE 9 
was prepared. Addition of 0.1% of the adduct to the 
polyerization system of Example 6 resulted in introduc- 
tion of fluorescent chromophore by condensation with 
aldehyde groups to the addition polymerized copoly- 
mer. 40 
EXAMPLE 10 
Dispersible iron oxide was prepared by dissolving 10 
g of ferrous chloride and 13.5 g of ferric chloride in 210 
cc of 1 % w/v polyethylene imine (M.W. 1800) aqueous 45 
solution. 50% NaOH was qdded to pH 7. The reaction 
mixture was refluxed for 3 hours, dialyzed extensively 
against water and separated magnetically three times 
from non-magnetic particles. The magnetic polyethyl- 
ene imine-iron oxide particles were redispersed in water 50 
and then sonicated with a clinical sonicator for 10 min- 
utes. Magnetic particles having a diameter of 300 Ang- 
stroms with amine groups on the surface were formed. 
When 1% of the polyethylene imine-iron oxide is added 55 
to the solution of mononers of Example 6 and subjected 
to gamma irradiation microspheres containing a disper- 
sion of magnetic iron particles is produced. 
EXAMPLE 11 
The Acrolein methacrylic acid copolymer micro- 
spheres were oxidized to convert the aldehyde groups 
to carboxyl adding 30.5 ml H20 and 90 ml of H202 
(30%) to 14.5 ml of an acrolein microsphere suspension 
(33 mg/ml). The suspension was stirred by a magnetic 65 
stirrer for 20 hours. The microspheres were then 
washed three times and then centrifuged for 15 minutes 
in water. The results are shown in FIG. 3. 
30 
An adduct of 1,6-diaminohexane (DAH) and FITC 35 
60 
10 
EXAMPLE 12 
2 mg of SDS powder was added to 10 cc of 5% (v/v) 
ACR solution and irradiated for 4 hours with a cobalt 
gamma source at 0.12 Mr/h and centrifuged 3 times. 
The particles were not visible. Their size as determined 
under an electron microscope was about 300-500 Ang- 
stroms. 
When the SDS content was increased to 50 mg, the 
particles were too small to be centrifuged. After dialyz- 
ing for several days their size as determined by SEM 
was about 170 to 340 Angstroms. 
The marking of cell surface receptors by means of 
fluorescent, non-fluorescent or magnetic fluorescent 
PGL microspheres was found to be simple and efficient 
as evidenced by numerous tests using fixed human or 
animal antibody labeled cells. 
The reactivity is similar to polyglutaraldehyde micro- 
spheres. However, no significant aggregation was ob- 
served during reactions with amines, diamines or prote- 
ins under a variety of experimental conditions. The 
microspheres are preferably very small in size from 100 
Angstroms to 100 microns, generally from 500 Ang- 
stroms to 10 microns so that specific receptor sites on a 
cell surface can be tagged. 
EXAMPLE 13 
To 2.5 ml of a water suspension of acrolein micro- 
spheres (total 15 mg) was added 0.5 of a 2 mg 1 ml 
solution of 125 Iodine labeled goat immunoglobulin G 
(spec. activity 1 X 105 cpm/mg) in PBS. The mixture 
was rotated for 3 hrs. and 400 microliters aliquots were 
taken at 0,30,60,120 and 180 minutes. Aliquot were 
immediately added to 400 ml of a 1 % (w/v) solution of 
egg albumin in PBS and centrifuged at 15,OOOxg for 4 
min., resuspended and washed once in PBS as above. 
The acrolein microspheres exhibited direct binding of 
about 7-9% by weight of antibody whereas a control 
HEMA-BAM microsphere was able to bind less than 
1% by weight of the microsphere. Results are illus- 
trated in FIG. 4. 
EXAMPLE 14 
Binding of Methotrexate to Polyacrolein Microspheres 
I. Preparation of Microspheres 
[ lo%]-Total monomer concentration 
90% Acrolein 
10% Methacrylic Acid 
in 25 mlO.4% PEO 100,OOO MW 
pH 2.8 
Degas with Nitrogen 
Co Gamma Radiation 5h; Dose-0.12 M i c h .  
Wash 3 x  
Resuspend 36 ml H20 
Cone: 27.5 mg/ml 
Yield: 46.13% 
50 mg of microspheres 
0.6 ml DAH (80% aqueous solution) 
11. Reaction of Microspheres with 1-6 Diaminohexane 
Repeat 4 hr. with shaking at room temperature 
Wash 3~ 
Resuspend in 10 ml H20 
Add 20 mg of carbodiimide to 50 mg of DAH micro- 
Sonicate 10 minutes 
Adjust pH to 6 w/ Na H2 Po4 
111. Reaction of Microspheres with Carbodiimide 
spheres 
4,622,3 62 
11 12 
Add 10 mg methotrexate in 2 ml H20 
Check to be sure pH is still 6.0 
Sonicate 2 minutes 
Shake overnight at room temperature 
Spin down 3X 
Take spectrum of first supernate. Spectrum indicates 
that more than 90% of methotrexate adducted with 
the microspheres. 
of desirable sizes can be conjugated with proteins in a 
simple and convenient manner, therefore offer a poten- 
tial for large scale immunological cell sorting as well as 
other applications. 
It is to be understood that only preferred embodi- 
ments of the invention have been described and that 
numerous substitutions, modifications and alterations 
are permissible without departing from the spirit and 
scope of the invention as defined in the following 
5 
A new convenient immunoreagent in form of acro- 10 claims. 
lein copolymer microspheres was synthesized in a vari- 
ety of sizes and with a relatively narrow size distribu- 
tion. High intensity of fluorescence can be imparted to 
the microspheres during or after polymerization. The 
with antibodies, enzymes and other proteins in a single 
step. Therefore this immunoreagent eliminates the pre- 
viously used intermediate steps in which the cyanogen 
bromide and carbodiimide reaction was used. The high 
specificity of the microspheres, at least as far as human 20 
synthetic modification yields fluorescent, magnetic mi- 
crospheres for a large number of potential applications. 
vention contain approximately twice as many aldehyde 25 
groups as the comparable glutaraldehyde copolymer 
microspheres. 
The use of magnetic particles has created a great deal 
of interest in biochemical research and clinical medicine 
I claim: 
1. A composition comprising the adduct of an alde- 
hyde reactive material selected from proteins, pharma- 
ceuticals and fluorescent chromophores with a micro- 
mixture containing: 
aldehyde functional groups permit covalent bonding 15 sphere of the addition interpolymerizate of a monomer 
20 to 90 percent by weight of an addition polymeriz- 
able unsaturated aldehyde selected from acrolein 
and C1 to c8 aryl, alkyl or cycloalkyl derivatives 
thereof; and 
izable, polyunsaturated cross-linking agent. ' 
rbc is concerned is a property* A minor 0.1 to 20 percent by weight of an addition copolymer- 
2. A composition according to claim l in which tlie 
weight of at least one addition copolymerizable, mono- 
unsahrated, freely water soluble acrylic comonomer 
substituted with a hydrophilic substituent selected from 
amine, carboxyl or hydroxyl. 
The polyacrolein microspheres Of this in- interpolymerizate further 10 to 50 percent by 
when used as supports for immobilized enzymes. Their 30 
easy retrieval from liquors containing colloids and un- 
ration of proteins and chemical compounds by affinity 4. A according to in which the 
chromagraphy can be simplified by elimination of te- 
in which the 
3* A according to in the form Of 
microspheres having a diameter from 500 
dissolved solids should be of practical value. The sepa- stroms to lo microns. 
diameter is from loo Angstroms to 2000 Angstroms. 
centrifugation procedures and column chroma- 35 5. A composition according to 
tography steps. Magnetic particles have also recently 
been tested in radioimmunoassay techniques in hyper- 
themia treatment of cancer, in guidance of magnetic 
particles to a vascular malformation such as cerebral 
aneurism with the intent to seal the defect by inducing 40 
thrombosis. 
blood flow or vehicles for drug delivery. The first SUC- 
cessful application of magnetic immunomicrospheres to 
the separation of B and T cells has been demonstrated. 45 
There is little doubt that physical sorting of cell subpop- 
ulations has become a necessity. Many separation meth- 
ods, while useful are limited by the restricted set of 
parameters upon which separation can be based and by 
the fact that they are batch techniques. 
New flow cytometers and sorters permit quantitative 
multiparameter measurements and sorting based on 
these measurements, but are limited as far as the number 
of cells that can be separated in a given time. Magnetic 
cell sorters have the potential of cell separation in a 55 
continuous process. Evidence obtained using model cell 
is 
6. A composition according to claim 5 in which the 
pharmaceutical is an amine substituted chemotherapeu- 
tic agent. 
7. A composition according to Claim 1 in which the 
aldehyde is selected from acrolein, methacrolein, alpha- 
Other proposed applications have been as tracers of ethyl acrolein, dPha-butYlacrolein, abha-chloroa- 
crolein, beh-phenylacrolein, alpha-cyclohexylacrolein 
and alpha-decylacrolein. 
8. A composition according to claim 7 in which the 
cross-linking agent is present in an amount from 6 to 
12% by weight and is selected from a polyvinyl diene or 
triene capable of addition polymerization with the co- 
valent bonding monomer. 
9. A composition according to claim 7 in which the 
copolymer further includes 0.05% to 5% by weight of 
a copolymerizable fluorescent chromophore monomer. 
10. A composition according to claim 1 in whjch the 
proteins are selected from antibodies or enzymes. 
11. A composition according to claim 7 in which the 
microspheres contain a dispersion of magnetic particles. 
50 
systems indicates that magnetic immunomicrospheres * * * * *  
60 
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